HIV Vaccine Study Needs Subjects
Vaccine Research Center scientists seek persons 18–60 years old who are living with HIV for a research study. The study evaluates an investigational product targeting the HIV virus to determine if it is safe and can generate an immune response. Compensation is provided. For more information, call 1-866-444-1132 (TTY 1-866-411-1010) or email email@example.com. Se habla español.
Volunteers with Leukemia Needed
NHLBI researchers need volunteers with CLL (chronic lymphocytic leukemia) or small lymphocytic lymphoma (SLL) for a new investigational treatment study. Researchers are adding pembrolizumab (an immunotherapy agent) to standard treatment. If you have received treatment for CLL and progressed or have high-risk genetic changes, such as deletion 17p, TP53 mutation, NOTCH1 mutation or complex cytogenics, you may be interested in participating. To learn more, call the Office of Patient Recruitment at 1-866-444-2214 (TTY 1-866-411-1010). Read more online at https://go.usa.gov/xnYae. Refer to study 17-H-0118.
NIDDK Study Seeks Overweight Men
NIDDK researchers are seeking overweight/obese men, 18–50 years old, to participate in a study looking at a potential link between consumption of processed foods and the development of metabolic syndrome. Participants will be required to remain in the hospital for 1 month on 2 separate occasions and eat only the meals provided by NIH during that time. Compensation is provided. To learn more, call the Office of Patient Recruitment at 1-866-444-2214 (TTY 1-866-411-1010). Read more at https://go.usa.gov/xRRE7.
Flu Vaccine Study Recruits Healthy Volunteers
Vaccine Research Center researchers seek healthy volunteers, 18–70 years old, for an investigational influenza vaccine study. Scientists are testing new vaccines to determine whether they are safe and effective in preventing the flu. Compensation is provided. For more information, call 1-866-833-5433 or email firstname.lastname@example.org. Read more at https://go.usa.gov/xNH7U. Refer to study VRC316.
NHLBI Study Needs Patients
NHLBI researchers are testing two low doses of danazol on individuals with short telomere disease and bone marrow disease, lung or liver disease. For more information, call the Office of Patient Recruitment, 1-866-444-2214 (TTY 1-866-411-1010). Read more at https://go.usa.gov/xnPYm. Refer to study 18-H-0004.